Ekso Bionics Holdings, Inc.

NASDAQ
EKSO
paper.types.company
Rentabilité sur six mois: -56.85%
Rendement en dividendes: 0%
Secteur: Healthcare

0.2999 $

0 $ 0%
0.2524 $
1.49 $

paper.min_max_per_year

Calendrier des promotions Ekso Bionics Holdings, Inc.

Calendrier avancé Graphique simple
Financial Markets by TradingView

À propos de l'entreprise Ekso Bionics Holdings, Inc.

Ekso Bionics Holdings, Inc. designs, develops, sells, and rents exoskeleton products in the Americas, Europe, the Middle east, Africa, the Asia Pacific, and internationally. It operates in two segments, EksoHealth and EksoWorks. The EksoHealth segment designs, engineers, manufactures, and markets exoskeletons for applications in the medical markets. The EksoWorks segment designs, engineers, manufactures, and markets exoskeleton devices to allow able-bodied users to perform difficult repetitive work for extended periods.

plus de détails
The company also provides EksoNR, a wearable bionic suit and rehabilitation device that assists physical therapists and physicians to treat patients with acquired brain injury, stroke, and spinal cord injury; Ekso Indego Therap, an adjustable and lower-limb powered exoskeleton; and Ekso Indego Personal, a powered lower limb orthosis. It has a license agreement with Lockheed Martin Corporation. The company was incorporated in 2005 and is headquartered in San Rafael, California.
Ajouter à la liste de comparaison
Ajouter à la liste de surveillance
Ajouter au portefeuille
Ajouter un avis de prix

Paramètres de base

IPO date
2014-01-16
ISIN
US2826443010
Industry
Health Care Equipment & Supplies
Sector
Health Care
Валюта
usd
Валюта отчета
usd
Сайт
lien
Tous les paramètres

Grade

Sous-estimation
Nom Signification Grade
P/S 0.6861 10
P/BV 0.9678 9
P/E 0 0
Efficacité
Nom Signification Grade
ROA -40.78 0
ROE -89.52 0
ROIC 0 0
Dividendes
Nom Signification Grade
Rendement en dividendes 0 0
DSI 0 0
Croissance moyenne du dividende 0 0
Devoir
Nom Signification Grade
Debt/EBITDA -0.6329 10
Debt/Ratio 0.2245 10
Debt/Equity 1.1 8
Impulsion de croissance
Nom Signification Grade
Rentabilité Revenue, % 101.4 10
Rentabilité Ebitda, % -18.51 0
Rentabilité EPS, % -76.29 0
Plus de détails

paper.price.prices

Prix Common.min. Common.max. Changement paper.changes_in_industry paper.changes_in_index
common.calendar.number_days.1 0.2999 $ 0 $ 0 $ 0 % 0 % 0 %
common.calendar.number_days.7d 0.2786 $ 0 $ 0 $ 7.65 % 0 % 0 %
common.calendar.number_days.30d 0.4907 $ 0.2524 $ 0.3743 $ -38.88 % 0 % 0 %
common.calendar.number_days.90d 0.5165 $ 0.2524 $ 0.5085 $ -41.94 % 0 % 0 %
common.calendar.number_days.180d 0.695 $ 0.2524 $ 0.83 $ -56.85 % 0 % 0 %
common.calendar.number_days.1y 1.18 $ 0.2524 $ 1.49 $ -74.58 % 0 % 0 %
common.calendar.number_days.3y 1.81 $ 0.2524 $ 3.1 $ -83.43 % 0 % 0 %
common.calendar.number_days.5y 3.87 $ 0.2524 $ 13.07 $ -92.25 % 0 % 0 %
common.calendar.number_days.10y 0 $ 0.1858 $ 13.07 $ 0 % 0 % 0 %
common.calendar.number_days.ytd 0.6399 $ 0.2524 $ 0.83 $ -53.13 % 0 % 0 %

Principaux propriétaires

Entreprises similaires

P/E & P/BVEV/Ebitda & Debt/Ebitda


Gestion d'entreprise

Superviseur Titre d'emploi Paiement Année de naissance
Mr. Scott G. Davis CEO & Director 637.02k 1970 (55 années)
Mr. Jerome Wong Chief Financial Officer 491.39k 1974 (51 année)
Mr. Jason C. Jones Chief Operating Officer 447.42k
Ms. Rachael Anderson Global Director of Marketing & Strategic Growth N/A
Ms. Ann Cookson Human Resources Director N/A
Ms. Foon Lim Chwee President of APAC N/A
Mr. Stephan Aderhold Senior VP & GM of EMEA N/A

Informations sur l'entreprise

Adresse: United States, San Rafael. CA, 101 Glacier Point - Ouvrir dans google maps, Ouvrir les cartes yandex
Site web: https://www.eksobionics.com